Stories tagged: Motley Fool
SUNDAY, FEB. 26, 2017
Motley Fool: AMC down, but don’t count it out
Shares of AMC Networks (Nasdaq: AMCX), the network behind the hit show “The Walking Dead,” has acted somewhat zombielike, falling 30 percent in 2016 – and drawing the attention of …
SUNDAY, FEB. 19, 2017
Motley Fool: Look to biotech sector for undervalued stocks
With the stock market trading near an all-time high, it’s hard to find undervalued stocks. You can find some in the biotechnology sector, though. Consider Celgene (Nasdaq: CELG).
SUNDAY, FEB. 12, 2017
The Motley Fool: AT&T stock offers solid income
AT&T (NYSE: T) is not a perfect investment: The company has a high debt load and primarily operates in the increasingly competitive wireless industry. However, it has been around as …
SUNDAY, FEB. 5, 2017, 5:30 A.M.
Motley Fool: Amgen a biotech blue chip
With a market value recently topping $110 billion, biotechnology titan Amgen (NASDAQ: AMGN) is a blue-chip company whose stock has been held back by bad news.
SUNDAY, JAN. 29, 2017, 4:45 A.M.
Motley Fool: After transformation, Big Blue is generating green
After a few years of causing pain for investors, shares of IBM (NYSE: IBM) bounced back in 2016, gaining around 20 percent. The company famously spent much of the last …
SUNDAY, JAN. 22, 2017
Alphabet’s portfolio of innovative projects could pay off over long term
In August 2015, the company formerly known as Google changed its name and corporate structure to better reflect its business model and strategy. Alphabet (Nasdaq: GOOGL, GOOG) is now a …
SUNDAY, JAN. 15, 2017, 5:33 A.M.
Overvalued or not, Amazon.com stock value has surged
The main reason many have passed up shares of Amazon.com (Nasdaq: AMZN) is that they think the shares are overvalued. The stock has seemed overvalued for many years, though – …
SUNDAY, JAN. 8, 2017, 5:30 A.M.
Drugmaker brings innovative drugs to market
Danish drug giant Novo Nordisk (NYSE: NVO), a kingpin in the diabetes space, disappointed Wall Street and investors following the release of its third-quarter results in late October. The company …
SUNDAY, JAN. 1, 2017
The Motley Fool: Medical device king Medtronic warrants closer look
If you’re seeking a company that offers regular dividend increases and stable cash flow, consider medical device king Medtronic (NYSE: MDT). The company has increased its dividend for 39 years …
SUNDAY, DEC. 25, 2016
The Motley Fool: CVS Health has a healthy future
It’s been a tough road recently for shareholders of drugstore giant CVS Health (NYSE: CVS). The company has shown moderate results in its front-of-the-store business (think shampoo, diapers, soap, chips …
SUNDAY, DEC. 18, 2016
The Motley Fool: Apparel giant overcomes forgettable name to deliver unforgettable performance
Some of the best stocks fly under the radar of most investors. V.F. Corp. (NYSE: VFC), with an eminently forgettable name, is one such company.
SUNDAY, DEC. 11, 2016
The Motley Fool: Calling Verizon
Over the trailing 12 months, Verizon has generated more than $28 billion in cash from operations, allowing it to reinvest in its business while leaving plenty left over for its …
SUNDAY, DEC. 4, 2016
The Motley Fool: Skyworks Solutions takes to the skies
Skyworks Solutions is a play on the future of the Internet of Things (IoT).
SUNDAY, NOV. 27, 2016
The Motley Fool: Winning profits with video games
Shares of video game developer Activision Blizzard (Nasdaq: ATVI) stock have averaged annual gains of nearly 21 percent over the past 20 years. The stock has been trading near its …
SUNDAY, NOV. 20, 2016
The Motley Fool: Take a drive with affordable GM
Looking for a stock trading at a discount with a high dividend yield and future catalysts that could boost earnings? General Motors (NYSE: GM) fits the bill.
SUNDAY, NOV. 13, 2016
The Motley Fool: A diversified GlaxoSmithKline is delivering
If you’re looking for a high-yield, low-volatility stock, consider big pharma stalwart GlaxoSmithKline.
SUNDAY, NOV. 6, 2016
The Motley Fool: Priceline Group more than a travel group
The Motley Fool Take If you’ve been assuming that The Priceline Group (Nasdaq: PCLN) is just another “me too” travel site, you’re wrong. It actually runs a collection of industry-leading …
SUNDAY, OCT. 30, 2016
The Motley Fool: Dividends and growth with Bristol-Myers
The Motley Fool Take Shares of Bristol-Myers Squibb (NYSE: BMY) were recently down about 30 percent from their all-time high in July. That leaves the stock more attractively priced and …
SUNDAY, OCT. 23, 2016
The Motley Fool: Reading Facebook
The Motley Fool Take Facebook (Nasdaq: FB) has been outperforming Wall Street analyst expectations for revenue and earnings during the past few years, and analysts expect the company to grow …
SUNDAY, OCT. 16, 2016
The Motley Fool: Grocery giant Kroger remains a super market for investors
The Motley Fool Take Shares of grocery giant Kroger (NYSE: KR) recently hit a 52-week low, making it even more attractive as an investment. Kroger has been facing challenges such …
SUNDAY, OCT. 9, 2016
The Motley Fool: A towering opportunity for wireless investing
It’s not just wireless technology that enables big growth in smartphone data usage. Infrastructure, such as the companies that build and install cellular towers, play a key role, too.
SUNDAY, OCT. 2, 2016
The Motley Fool: Want a Bite of This Apple?
The Motley Fool Take Apple (Nasdaq: AAPL) has released its new iPhone 7 phones, and early reports are that it’s selling well. If these new phones can alleviate the concern …
SUNDAY, SEPT. 25, 2016
The Motley Fool: Microsoft’s Plans Are Paying Off
The Motley Fool Take Microsoft (Nasdaq: MSFT) is undergoing big changes that include becoming a major player in cloud computing. In its recently reported fourth quarter, Microsoft’s intelligent cloud segment …
SUNDAY, SEPT. 18, 2016
Motley Fool: Cost-cutting at Biogen turns biotech company into promising stock purchase
The Motley Fool Take Biogen Inc. (NASDAQ: BIIB) is one of the oldest and largest biotech companies, and its shares have recently been trading at attractive levels. The stock has …
SUNDAY, SEPT. 11, 2016
The Motley Fool: A Biotech Bargain
The Motley Fool Take Gilead Sciences is a market leader among biotech companies, with a market value recently topping $100 billion. It has an enormously valuable portfolio of drugs focused …
SUNDAY, SEPT. 4, 2016
The Motley Fool: A Money Mouse
The Motley Fool Take Walt Disney (NYSE: DIS) is the undisputed global entertainment king, with enormously valuable brands such as Disney itself, ESPN, ABC, Pixar and Marvel. In addition, it …
SUNDAY, AUG. 28, 2016
The Motley Fool: eBay operates in a growing industry
The Motley Fool Take E-commerce is one of the most promising industries around. Accounting for a modest 7.5 percent of all retail transactions in the United States, it has a …
SUNDAY, AUG. 21, 2016
The Motley Fool: Chipping away for the long term with NXP Semiconductors
NXP Semiconductors (NASDAQ: NXPI) is the world’s largest automotive chipmaker, and it also supplies the smartphone industry and others with chips. The company is a long-term play on the interconnectedness …
SUNDAY, AUG. 14, 2016
The Motley Fool: Netflix more attractive after recent drop
If you’re looking for fast growers and can stomach some risk, consider Netflix (NASDAQ: NFLX) for your portfolio. It recently reported some disappointing numbers for its second quarter, with its …
SUNDAY, JULY 31, 2016
The Motley Fool: A stock to bank on
After the Federal Reserve raised its federal funds target rate for the first time in nearly a decade in December and led many to expect several more hikes in 2016, …